Search results
Results from the WOW.Com Content Network
CareSource is a nonprofit that began as a managed health care plan serving Medicaid members in Ohio. Today, it provides public health care programs including Medicaid, Medicare, and Marketplace. The company is headquartered in Dayton, Ohio. It is the largest Medicaid plan in Ohio and is second largest in the United States. [2] [3]
The Medicaid Drug Rebate Program is a program in the United States that was created by the Omnibus Budget Reconciliation Act of 1990 (OBRA'90). The program establishes mandatory rebates that drug manufacturers must pay state Medicaid agencies related to the dispensing of outpatient prescription drugs covered by Medicaid .
CareStar has provided case management services since 1988 in various mid-western states, predominantly in Ohio and Indiana.In 2004, CareStar signed a five-year, $140 million contract with the Ohio Department of Job and Family Services to provide case management services for its medicaid waiver homecare program.
Medicaid is a means-tested health and medical services program for low income households with few resources. Individuals must meet certain criteria to qualify. These criteria vary between states.
CAMDEN, N.J. (AP) — The federal government is planning to allow states to use Medicaid funds to provide drugs to The post US plans to allow Medicaid for drug treatment in prisons appeared first ...
Prior to July 2013, ODJFS was also the state agency responsible for the administration of Ohio's Medicaid program. In July 2013, a new state agency was created, the Ohio Department of Medicaid (ODM), Ohio’s first Executive-level Medicaid agency. ODJFS employs about 2,300 full time employees and has an annual budget of $3.3 billion. [2]
Despite the importance Medicaid places on providing access to health care, many states have inconsistent policies toward paying for medications used to treat opiate addiction. The American Society of Addiction Medicine surveyed each state’s Medicaid program to determine which medications are covered and if any limitations exist.
The rule shift would also require state Medicaid programs to begin covering GLP-1s for obesity, making the drugs — which can cost upward of $1,000 a month out of pocket — much more widely ...